Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000007976
JPRN-UMIN000007976
Completed
未知

Japan-Based clinical ReseArch Network for Diabetes Registry - J-BRAND Registry

J-BRAND Registry Study Group0 sites5,208 target enrollmentMay 21, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiabetes type 2

Overview

Phase
未知
Intervention
Not specified
Conditions
Diabetes type 2
Sponsor
J-BRAND Registry Study Group
Enrollment
5208
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

The same level of safety and efficacy was shown between groups A and B, confirming the usefulness of alogliptin for the treatment of type 2 diabetes

Registry
who.int
Start Date
May 21, 2012
End Date
December 31, 2017
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
J-BRAND Registry Study Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Any subject who meets any of the following criteria will not qualify for entry into the study: (1\)Patients using parenteral hypoglycemic agents (insulin and glucagon\-like peptide\-1 \[GLP\-1] receptor agonists) (2\)Patients with severe ketosis, diabetic coma or precoma, severe infection, or serious trauma and patients under the perioperative management (3\)Pregnant or lactating women (4\)Patients judged by the principal investigator or sub\-investigator to be ineligible for participation as study subjects for any other reason

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
To Evaluate Clinical Efficacy and Safety of Diabetes-Specific Formula (Nutren Diabetes)Diabetes Mellitus
NCT05859165Société des Produits Nestlé (SPN)233
Completed
Phase 3
Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular ComplicationsDiabetes Mellitus, Type 2
NCT00097786Novartis Pharmaceuticals9,306
Completed
Not Applicable
Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) The large trial to improve the medical care of the family doctors for type 2 diabetes patients and to decrease dropout rate of these patients.Type 2 Diabetes Mellitus
JPRN-UMIN000002186Japan Foundation for the Promotion of International Medical Research Cooperation3,750
Completed
Not Applicable
Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) Pilot research about efficiency of a system supporting type 2 diabetes mellitus medical care by a family doctorType 2 Diabetes Mellitus
JPRN-UMIN000000481Japan Foundation for the Promotion of International Medical Research Cooperation2,400
Completed
Phase 3
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 DiabetesDiabetesDiabetes Mellitus, Type 2
NCT01059799Novo Nordisk A/S435